tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools30% OFF!
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

URGN Stock Latest News

UroGen Pharma price target lowered to $32 from $34 at Oppenheimer
The FlyUroGen Pharma price target lowered to $32 from $34 at Oppenheimer
19d ago
URGN
UroGen Pharma trading resumes
PremiumThe Fly
UroGen Pharma trading resumes
20d ago
URGN
UroGen Pharma trading halted, volatility trading pause
PremiumThe Fly
UroGen Pharma trading halted, volatility trading pause
20d ago
URGN
UroGen Pharma reports Q1 EPS (97c), consensus (87c)
PremiumThe Fly
UroGen Pharma reports Q1 EPS (97c), consensus (87c)
20d ago
URGN
Urogen Pharma (URGN) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Urogen Pharma (URGN) Q1 Earnings Cheat Sheet
22d ago
URGN
UroGen Pharma presents sub-analysis of Jelmyto trial
PremiumThe FlyUroGen Pharma presents sub-analysis of Jelmyto trial
28d ago
URGN
UroGen Pharma says ATLAS results show ‘robust’ UGN-102 durability
PremiumThe Fly
UroGen Pharma says ATLAS results show ‘robust’ UGN-102 durability
28d ago
URGN
UroGen Pharma announces FDA acceptance of UGM-103 IND
PremiumThe Fly
UroGen Pharma announces FDA acceptance of UGM-103 IND
2M ago
URGN
UroGen Pharma files patent infringement action against Teva Pharmaceuticals
PremiumThe Fly
UroGen Pharma files patent infringement action against Teva Pharmaceuticals
2M ago
URGN
UroGen Pharma price target lowered to $34 from $35 at Oppenheimer
PremiumThe Fly
UroGen Pharma price target lowered to $34 from $35 at Oppenheimer
3M ago
URGN
Urogen Pharma’s UGN-102 Faces Crucial Test: Durability of Response Key to Drug’s Approval Prospects
PremiumCompany Announcements
Urogen Pharma’s UGN-102 Faces Crucial Test: Durability of Response Key to Drug’s Approval Prospects
3M ago
URGN
URGN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
URGN Upcoming Earnings Report: What to Expect?
3M ago
URGN
UroGen Pharma to Present at TD Cowen Health Care Conference
PremiumCompany AnnouncementsUroGen Pharma to Present at TD Cowen Health Care Conference
3M ago
8K
URGN
Teva Challenges UroGen Pharma’s Jelmyto Patent Rights
PremiumCompany Announcements
Teva Challenges UroGen Pharma’s Jelmyto Patent Rights
3M ago
8K
URGN
UroGen Pharma Shares Insights at Guggenheim Healthcare Talks
PremiumCompany Announcements
UroGen Pharma Shares Insights at Guggenheim Healthcare Talks
4M ago
8K
URGN
UroGen Pharma price target raised to $35 from $32 at Oppenheimer
PremiumThe Fly
UroGen Pharma price target raised to $35 from $32 at Oppenheimer
4M ago
URGN
UroGen initiates submission of rolling NDA to FDA for UGN-102
PremiumThe Fly
UroGen initiates submission of rolling NDA to FDA for UGN-102
4M ago
URGN
UroGen in deal with medac GmbH to develop formulation for urothelial cancers
PremiumThe Fly
UroGen in deal with medac GmbH to develop formulation for urothelial cancers
5M ago
URGN
Urogen Pharma (URGN) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Urogen Pharma (URGN) Q3 Earnings Cheat Sheet
7M ago
URGN
UroGen Pharma announces rolling NDA submission for UGN-102 to begin in January
PremiumThe FlyUroGen Pharma announces rolling NDA submission for UGN-102 to begin in January
8M ago
URGN
UroGen Pharma files to sell 12.58M ordinary shares for holders
PremiumThe Fly
UroGen Pharma files to sell 12.58M ordinary shares for holders
9M ago
URGN
TD Cowen biotech analyst to hold an analyst/industry conference call
PremiumThe Fly
TD Cowen biotech analyst to hold an analyst/industry conference call
10M ago
URGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >